Sheng-li Xue, Md

This study tests a combination of two drugs, venetoclax and azacitidine, in people newly diagnosed with a rare and hard-to-treat leukemia called acute leukemia of ambiguous lineage. The goal is to see if this treatment can help more patients achieve remission. About 23 participan…

This study tests a drug called Inotuzumab Ozogamicin (INO) in people with acute lymphoblastic leukemia (ALL) who still have tiny amounts of leukemia cells (called minimal residual disease, or MRD) after a stem cell transplant. The goal is to see if INO can clear these leftover ce…